Based on the PetMed Express Inc stock forecast from 2 analysts, the average analyst target price for PetMed Express Inc is USD 3.75 over the next 12 months. PetMed Express Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of PetMed Express Inc is Slightly Bearish, which is based on 5 positive signals and 7 negative signals. At the last closing, PetMed Express Inc’s stock price was USD 3.16. PetMed Express Inc’s stock price has changed by +4.64% over the past week, -25.65% over the past month and -23.11% over the last year.
No recent analyst target price found for PetMed Express Inc
No recent average analyst rating found for PetMed Express Inc
Company Overview PetMed Express Inc
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida. Read Less
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and...Read More
Frequently Asked Questions About PetMed Express Inc (PETS) Stock
Based on ratings from 2 analysts PetMed Express Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on PETS's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for PETS is USD 3.75 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 3.5.
PETS stock's Price/Earning ratio is 351.00.
Our analysis grades PETS stock's Price / Earning ratio at F. This means that PETS stock's Price/Earning ratio is above 67% of the stocks in the Pharmaceutical Retailers sector in the NSD exchange.
Based on this PETS may be a overvalued for its sector.
The last closing price of PETS's stock was USD 3.16.
The most recent market capitalization for PETS is USD 0.07B.
Based on targets from 2 analysts, the average taret price for PETS is projected at USD 3.75 over the next 12 months.
This means that PETS's stock price may go up by +18.67% over the next 12 months.
We can't find any ETFs which contains PetMed Express Inc's stock.
As per our most recent records PetMed Express Inc has 287 Employees.
PetMed Express Inc's registered address is 420 South Congress Avenue, Delray Beach, FL, United States, 33445.
You can get more information about it from PetMed Express Inc's website at https://www.1800petmeds.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About PetMed Express Inc (PETS) Stock
Based on ratings from 2 analysts PetMed Express Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on PETS's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for PETS is USD 3.75 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 3.5.
PETS stock's Price/Earning ratio is 351.00.
Our analysis grades PETS stock's Price / Earning ratio at F. This means that PETS stock's Price/Earning ratio is above 67% of the stocks in the Pharmaceutical Retailers sector in the NSD exchange.
Based on this PETS may be a overvalued for its sector.
The last closing price of PETS's stock was USD 3.16.
The most recent market capitalization for PETS is USD 0.07B.
Based on targets from 2 analysts, the average taret price for PETS is projected at USD 3.75 over the next 12 months.
This means that PETS's stock price may go up by +18.67% over the next 12 months.
We can't find any ETFs which contains PetMed Express Inc's stock.
As per our most recent records PetMed Express Inc has 287 Employees.
PetMed Express Inc's registered address is 420 South Congress Avenue, Delray Beach, FL, United States, 33445.
You can get more information about it from PetMed Express Inc's website at https://www.1800petmeds.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PETS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
